Phenytoin, Free, Serum or Plasma

CPT: 80186
Print Share

Synonyms

  • Dilantin-125®
  • Dilantin®
  • Free Phenytoin
  • Phenytek®

Expected Turnaround Time

2 - 4 days


Related Documents


Specimen Requirements


Specimen

Serum or plasma


Volume

3 mL


Minimum Volume

1.5 mL


Container

Red-top tube or green-top (heparin) tube. Do not use a gel-barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant.


Collection

Transfer separated serum or plasma to a plastic transport tube. Draw specimen just prior to next dose.


Storage Instructions

Room temperature


Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/thaw cycles

Stable x3


Causes for Rejection

Gel-barrier tube; hemolysis; lipemia


Test Details


Methodology

Ultrafiltrate assayed by immunoassay


Reference Interval

Therapeutic: 1.0−2.0 μg/mL


Additional Information

Phenytoin is 90% bound, but only the free fraction circulates through plasma membranes and is biologically active. Because of rapid equilibration between free and bound portions of drugs, free levels are potentially important only in AEDs that are highly bound (ie, phenytoin but not carbamazepine). Measurement of the free fraction is not cost-effective on a routine outpatient basis, but may be clinically relevant in exceptional circumstances associated with alterations in the binding of phenytoin.1 Binding kinetics may be altered in uremia, hepatic disease, late pregnancy or postpartum, cases of head injury associated with a hypermetabolic state, and certain instances of polypharmacy, described below.2-4 Determination of free levels may also be helpful in overdosages, since only the free portion can be cleared by dialysis.

In renal disease, total phenytoin levels may generate falsely high values, leading to inadequate dosage. Dialysis may increase the amount of free phenytoin available.5 In hepatic disease, phenytoin competes with endogenous bilirubin for binding sites,6 and thus the need for a free level may be greatest if the total bilirubin level is high and albumin low. Available liver function tests are not predictive of free phenytoin levels in patients with liver disease.4

Drugs which compete for binding sites on albumin and which may displace phenytoin include valproic acid, acetazolamide, high doses of salicylic acid, phenylbutazone, ceftriaxone, nafcillin, and sulfamethoxazole.7 In a clinical setting in which one of these drugs is used with phenytoin and toxicity is suspected despite normal phenytoin levels, a free level may be useful.

The free phenytoin level can be approximated by the total phenytoin level in cerebrospinal fluid or saliva or other body fluids that are albumin-poor.


Footnotes

1. Theodore WH, Yu L, Price B, et al. The clinical value of free phenytoin levels. Ann Neurol. 1985 Jul; 18(1):90-93. 4037755
2. Levy RH, Mattson RH, Maldrum BS, et al. Antiepileptic Drugs. 5th ed. Philadelphia, Pa: Lippincott Williams and WIlkins; 2002.
3. Griebel ML, Kearns GL, Fiser DH, Woody RC, Turley CP. Phenytoin protein binding in pediatric patients with acute traumatic injury. Crit Care Med. 1990 Apr; 18(4):385-391. 1969339
4. Dasgupta A, Dennen DA, Dean R, McLawhon RW. Prediction of free phenytoin levels based on total phenytoin:albumin ratios. Am J Clin Pathol. 1991 Feb; 95(2):253-256. 1992618
5. Dasgupta A, Abu-Alfa A. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis: Role of uremic compounds. Am J Clin Pathol. 1992 Jul; 98(1):19-25. 1615921
6. Hooper WD, Bochner F, Eadie MJ, Tyrer JH. Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease. Clin Pharmacol Therapeutics. 1974 Mar; 15(3):276-282. 4815953
7. Dasgupta A, Dennen DA, Dean R, Mc Lawhon RW. Displacement of phenytoin from serum protein carriers by antibiotics: Studies with ceftriaxone, nafcillin, and sulfamethoxazole. Clin Chem. 1991 Jan; 37(1):98-100. 1988217

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
070763 Phenytoin, Free, Serum 3969-3 070763 Phenytoin, Free, Serum ug/mL 3969-3

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf